SunilBadveMD

Pathology • Atlanta, GA

Molecular Genetics, Anatomic Pathology, Clinical Pathology, Surgical Pathology

Professor and Vice Chair, Pathology Cancer Program Department of Pathology and Laboratory Medicine Emory University School of Medicine

Join to view full profile

Dr. Badve is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Badve's full profile

Already have an account?

Office
1364 Clifton Road NE, Room H184
Atlanta, GA 30322
Phone+1 404-712-8579

Education & Training

Montefiore Medical Center/Albert Einstein College of MedicineResidency, Pathology-Anatomic and Clinical, 1995 - 1998
Grant Medical CollegeClass of 1986

Certifications & Licensure

GA State Medical License 2021 - 2026
IN State Medical License 2002 - 2021
IL State Medical License 1999 - 2002
NY State Medical License 1999 - 2000
CT State Medical License 1998 - 1999
American Board of Pathology Anatomic Pathology & Clinical Pathology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the Breast Start of enrollment: 2009 Apr 01
Terminated
Not Applicable
Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE) Start of enrollment: 2019 Dec 10
Recruiting
Not Applicable
Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease Start of enrollment: 2020 Dec 14
Recruiting
Phase 3

Publications & Presentations

PubMed

Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial.
E Shelley Hwang, Terry Hyslop, Thomas Lynch, Marc D Ryser, Anna Weiss
JAMA. 2024-12-12
Academic Uphill Battle to Personalize Treatment for Patients With Stage II/III Triple-Negative Breast Cancer.
Marleen Kok, Robbert-Jan Gielen, Sylvia Adams, Jochen K Lennerz, Priyanka Sharma
Journal of Clinical Oncology. 2024-10-20
Identification of Glandular (Acinar)/Tubule Formation in Invasive Carcinoma of the Breast: A Study to Determine Concordance Using the World Health Organization Definit...
Yungtai Lo, Susan C Lester, Ian O Ellis, Sonali Lanjewar, Javier Laurini
Archives of Pathology & Laboratory Medicine. 2024-10-01

Journal Articles

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
Matthew P Goetz, Thomas J Saphner, Joseph A Sparano, Lynne I Wagner, Peter M Ravdin, Daniel F Hayes, Adam M Brufsky, Della F Makower, Sunil S Badve, Robert J Gray, Wil..., The New England Journal of Medicine

Press Mentions

Managing Central Nervous System Metastasis in Patients with HER2-Positive Breast CancerOctober 22nd, 2024
Susan G. Komen® Invests $21.7 Million in Research Focused on Improving Outcomes for Breast Cancer PatientsJune 22nd, 2022
Chronic Kidney Disease Medication Doesn’t Work, Shows StudyJune 28th, 2020
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member